These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 6771071)

  • 21. The photometric latex test for rheumatoid factors in patients with rheumatoid arthritis. I. correlation with other serologic tests.
    Dezelić N; Zergollern V; Dezelić G; Dürrigl T; Jurak H; Vitaus M; Androić S
    Z Rheumatol; 1978; 37(3-4):93-104. PubMed ID: 636670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of aggregate size on the binding and activation of the first component of human complement by soluble IgG aggregates.
    Doekes G; Vanes LA; Daha MR
    Immunology; 1982 Apr; 45(4):705-13. PubMed ID: 7068172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IgG 1 subclass specificity for IgG rheumatoid factors in patients with rheumatoid arthritis.
    Miyata M; Sato Y; Kasukawa R
    J Rheumatol; 1999 Jul; 26(7):1436-8. PubMed ID: 10405926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum IgG and IgM rheumatoid factors and complement activation in extraarticular rheumatoid disease.
    Jakle C; Feigal DW; Robbins DL; Shapiro R; Wiesner K
    J Rheumatol; 1985 Apr; 12(2):227-32. PubMed ID: 3875718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Routine measurement of IgM, IgG, and IgA rheumatoid factors: high sensitivity, specificity, and predictive value for rheumatoid arthritis.
    Swedler W; Wallman J; Froelich CJ; Teodorescu M
    J Rheumatol; 1997 Jun; 24(6):1037-44. PubMed ID: 9195506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of rheumatoid factors and normal human sera on immune complex-Fc gamma R interaction.
    Isturiz MA; Giordano M; Serebrinsky GP
    Clin Exp Immunol; 1983 Oct; 54(1):225-31. PubMed ID: 6225582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of six tests for circulating IgG complexes with special reference to IgM rheumatoid factors: analysis of systemic lupus erythematosus and rheumatoid arthritis series.
    Wager O; Lindström P; Räsänen JA; Kekomäki R; Ziola B; Salmi A; Isomäki H; Skrifvars B; Penttinen K
    Clin Exp Immunol; 1981 Oct; 46(1):149-60. PubMed ID: 7337967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential precipitation of the Clq subcomponent of the first complement component (C1) by polyethylene glycol from normal human serum and sera of patients with collagen diseases.
    Van Dijk H; Van Voorst J; Jankowski IG; Imhof JW; Kerckhaert JA
    Clin Exp Immunol; 1984 Aug; 57(2):495-501. PubMed ID: 6432386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 7S IgG rheumatoid factor and hidden 19S IgM rheumatoid factor in juvenile chronic arthritis.
    Roizenblatt S; Goldenberg J; Gabriel A; Hilário MO; Atra E
    Allergol Immunopathol (Madr); 1993; 21(5):197-200. PubMed ID: 8160565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The occurrence of circulating immune complexes and viral antigens in idiopathic thrombocytopenic purpura.
    Lurhuma AZ; Riccomi H; Masson PL
    Clin Exp Immunol; 1977 Apr; 28(1):49-55. PubMed ID: 558848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phagocytosis and degradation of DNA-antiDNA complexes by human phagocytes. Influence of rheumatoid factors.
    Lamers MC; de Groot ER; Roos D
    J Rheumatol; 1981; 8(6):880-8. PubMed ID: 7328563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Present status and problems with rheumatoid factor as a laboratory test].
    Ota T
    Rinsho Byori; 2003 Jul; 51(7):649-55. PubMed ID: 12924249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IgM-RF prevents complement-mediated inhibition of immune precipitation.
    Mitchell WS; Naama JK; Veitch J; Whaley K
    Immunology; 1984 Jul; 52(3):445-8. PubMed ID: 6745994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of human C1: analysis with Western blotting reveals slow self-activation.
    Hosoi S; Circolo A; Borsos T
    J Immunol; 1987 Sep; 139(5):1602-8. PubMed ID: 3624867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of the first component of complement, C1, by a monoclonal antibody recognizing the C chain of C1q.
    Heinz HP; Burger R; Golan MD; Loos M
    J Immunol; 1984 Feb; 132(2):804-8. PubMed ID: 6606678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mapping studies reveal unique epitopes on IgG recognized by rheumatoid arthritis-derived monoclonal rheumatoid factors.
    Bonagura VR; Artandi SE; Davidson A; Randen I; Agostino N; Thompson K; Natvig JB; Morrison SL
    J Immunol; 1993 Oct; 151(7):3840-52. PubMed ID: 7690818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical significance of IgG rheumatoid factor in patients with rheumatoid arthritis].
    Naka T; Kondo M; Mashima T
    Ryumachi; 1995 Jun; 35(3):530-7. PubMed ID: 7570206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relationship between the binding ability and the rate of activation of the complement component C1.
    Folkerd EJ; Gardner B; Hughes-Jones NC
    Immunology; 1980 Sep; 41(1):179-85. PubMed ID: 7429549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interference by rheumatoid factor with the detection of C-reactive protein by the latex agglutination method.
    Deyo RA; Pope RM; Persellin RH
    J Rheumatol; 1980; 7(3):279-87. PubMed ID: 7401063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of immunoglobulins in alternative complement pathway activation by zymosan. I. Human IgG with specificity for Zymosan enhances alternative pathway activation by zymosan.
    Schenkein HA; Ruddy S
    J Immunol; 1981 Jan; 126(1):7-10. PubMed ID: 6778918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.